Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain.

P Romualdi1, G Lesa, S Ferri

  • 1Department of Pharmacology, University of Bologna, Italy.

Brain Research
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group.

ESMO real world data and digital oncology·2026
Same author

Improved modeling of the electric field induced Lyman-α emission diagnostic for analyzing the Lyman-α signal emitted in the presence of electric and magnetic fields.

The Review of scientific instruments·2026
Same author

The role of a fixed combination of ibuprofen/paracetamol in the management of acute pain: an Italian expert narrative review.

European review for medical and pharmacological sciences·2026
Same author

Early Life Social Isolation Dysregulates Social Reward Processing, BDNF Signaling, and Intracellular Vesicular Sorting in the Nucleus Accumbens of Male and Female Rats.

Journal of neurochemistry·2025
Same author

Neuronavigated Retropharyngeal Anterior Screw Fixation of the Odontoid for the Treatment of C2 Type II Fractures: Case Report.

Acta neurochirurgica. Supplement·2023
Same author

Correlation Between Cervical Spine Sagittal Alignment and Clinical Outcome After Standalone Intersomatic Titanium Cage CeSPACE for Cervical Anterior Discectomy and Fusion in Cervical Degenerative Disk Diseases.

Acta neurochirurgica. Supplement·2023

Long-term opioid agonist use, including U-50,488H and morphine, significantly reduced prodynorphin gene expression in rat brain regions. This suggests chronic opiate exposure alters endogenous opioid system regulation at the gene expression level.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Opioid agonists are widely used for pain management.
  • The endogenous opioid system, including dynorphins, plays a crucial role in pain and reward pathways.
  • Understanding how chronic opioid exposure affects gene expression is vital for managing tolerance and addiction.

Purpose of the Study:

  • To investigate the impact of long-term opioid agonist administration on prodynorphin gene expression in the rat brain.
  • To examine the effects of specific kappa and mu opioid receptor agonists on prodynorphin mRNA and protein levels.

Main Methods:

  • Chronic intracerebroventricular administration of U-50,488H (kappa agonist) and morphine (mu agonist) in rats.
  • Measurement of prodynorphin mRNA levels using quantitative techniques.

Related Experiment Videos

  • Assessment of immunoreactive Dynorphin A (ir-Dynorphin A) levels in brain tissues.

    • Main Results:

    • Both U-50,488H and morphine markedly decreased prodynorphin mRNA levels in the hypothalamus, hippocampus, and striatum of tolerant rats.
    • Levels of ir-Dynorphin A remained largely unchanged, with exceptions in specific brain regions.
    • Chronic opiate treatment led to significant downregulation of prodynorphin gene expression.

    Conclusions:

    • Long-term administration of opioid agonists alters the regulation of the endogenous opioid system.
    • Prodynorphin gene expression is sensitive to chronic exposure to both kappa and mu opioid agonists.
    • These findings highlight molecular adaptations in the brain in response to sustained opioid treatment.